Player FM 앱으로 오프라인으로 전환하세요!
Ep. 44: “The Innate Immune System” Featuring Dr. Miriam Merad
Fetch error
Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on April 09, 2024 22:11 ()
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 350319089 series 2895470
Guest:
Dr. Miriam Merad is a Professor of Cancer Immunology and Director of the Marc and Jennifer Lipschultz Precision Immunology Institute at the Icahn School of Medicine at Mount Sinai. Her research focuses on dendritic cells and macrophages. She talks about tissue-resident macrophages in COVID-19 and cancer. She also discusses her new role as President of the International Union of Immunological Societies and bringing the international immunology community together at their upcoming meeting in South Africa.
Featured Products and Resources:
- Early-Bird Registration Is Open for IMMUNOLOGY2023!
- Free Wallchart: SARS-CoV-2 Structure and Life Cycle
The Immunology Science Round Up
NLRP3 Inflammasome Activation – Researchers used cryo-EM to identify the structure of the active NLRP3 inflammasome disk.
How the BCG Vaccine Induces Trained Immunity – The BCG vaccine triggers epigenetic modifications on alveolar macrophages via an intestinal microbiota-mediated pathway.
Immunotherapy for Type 1 Diabetes – Scientists examined the mechanism of action of low-dose interleukin-2 immunotherapy and identified a long-lived gene expression signature associated with potential anti-inflammatory effects.
pH Affects Interleukin-2 Anti-Tumor Activity – Researchers identified an interleukin-2 variant that retains its binding affinity in low pH environments.
Image courtesy of Dr. Miriam Merad
90 에피소드
Fetch error
Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on April 09, 2024 22:11 ()
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 350319089 series 2895470
Guest:
Dr. Miriam Merad is a Professor of Cancer Immunology and Director of the Marc and Jennifer Lipschultz Precision Immunology Institute at the Icahn School of Medicine at Mount Sinai. Her research focuses on dendritic cells and macrophages. She talks about tissue-resident macrophages in COVID-19 and cancer. She also discusses her new role as President of the International Union of Immunological Societies and bringing the international immunology community together at their upcoming meeting in South Africa.
Featured Products and Resources:
- Early-Bird Registration Is Open for IMMUNOLOGY2023!
- Free Wallchart: SARS-CoV-2 Structure and Life Cycle
The Immunology Science Round Up
NLRP3 Inflammasome Activation – Researchers used cryo-EM to identify the structure of the active NLRP3 inflammasome disk.
How the BCG Vaccine Induces Trained Immunity – The BCG vaccine triggers epigenetic modifications on alveolar macrophages via an intestinal microbiota-mediated pathway.
Immunotherapy for Type 1 Diabetes – Scientists examined the mechanism of action of low-dose interleukin-2 immunotherapy and identified a long-lived gene expression signature associated with potential anti-inflammatory effects.
pH Affects Interleukin-2 Anti-Tumor Activity – Researchers identified an interleukin-2 variant that retains its binding affinity in low pH environments.
Image courtesy of Dr. Miriam Merad
90 에피소드
모든 에피소드
×플레이어 FM에 오신것을 환영합니다!
플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.